A glutamine tug-of-war between cancer and immune cells: recent advances in unraveling the ongoing battle

Chemically Modified Platforms for Better RNA Therapeutics

MYC ASO Impedes Tumorigenesis and Elicits Oncogene Addiction in Autochthonous Transgenic Mouse Models of HCC and RCC

MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism